MCF-7 cells were treated with 0, 10, or 20 μM of Peptide 1 or Peptide 2 for 48h. by Deepu Dowarha (5673440)

Subjects:

S100A1 complete sequence indicating highlighted region selected for peptide construction, attaching it to HIV-TAT peptide forming Peptide 1 and its scramble arrangement in Peptide... by Deepu Dowarha (5673440)

Subjects:

Fig 9 - by Deepu Dowarha (5673440)

Subjects:

The p53-MDM2 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Subjects:

Analysis of WST-1 assay. by Deepu Dowarha (5673440)

Subjects:

The ¹H−¹⁵N HSQC spectra overlay of free ¹⁵N p53 (1–73) (red) and in complex with unlabelled S100A1 (yellow). by Deepu Dowarha (5673440)

Subjects:

Fig 16 - by Deepu Dowarha (5673440)

Subjects:

Competitive binding experiment. by Deepu Dowarha (5673440)

Subjects:

The MCF-7 and/or MDA-MB-468 cells were treated with or without 10 μM Peptide 1 for 48h. by Deepu Dowarha (5673440)

Subjects:

The p53-Peptide 1 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Subjects:

Aspirin-Triggered Resolvin D1 does not rescue barrier function in IL-1β-treated A549 cells. by Ruan Cox Jr. (789575)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 12 covariates chosen using subjective feature selection. by Dennis Ochola (11626912)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 17 covariates selected after recursive feature selection. by Dennis Ochola (11626912)

Drop point and rebound rounds^a effects for groups in the empirical and simulated data. by Daniel B. Shank (709756)

The solution of recovered compartment of model (1) asymptotically approaches to the endemic equilibrium for the data (54), the solution is decreasing with increasing in value of <i... by Dilber Uzun Ozsahin (18320075)

General conditions and periodontal parameters at baseline and follow-up in the sub-group analysis [moderately poor glycemic control (HbA1c; 7.0 to 10.0%)]. by Hirofumi Mizuno (4597621)

General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

Selection of crossing point. by Yanchun Li (248761)

Homocysteine decreases G9a expression both <i>in vitro</i> and <i>in vivo</i>. by Wenjing Lei (772749)

Hcy decreased the binding of G9a to the <i>COL1A1</i> promoter. by Wenjing Lei (772749)